Cancer Immunology and Immunotherapy Image close
Cancer Immunology and Immunotherapy on Hardback
Cancer Immunology and Immunotherapy on Hardback
Show Hide Adult Content
Cancer Immunology and Immunotherapy close

Non-Fiction Books:

Home  
Books  
Non-Fiction  
Professional & Technical  
Medicine  
Clinical & internal medicine  
Diseases & disorders  
Oncology

Cancer Immunology and Immunotherapy

Click to share your rating 0 ratings (0.0/5.0 average) Thanks for your vote!

Format:

Hardback
$533.99
Available from supplier

The item is brand new and in-stock with one of our preferred suppliers. The item will ship from a Mighty Ape warehouse within the timeframe shown.

Usually ships in 3-4 weeks
0 in Trolley

Buy Now, Pay Later with:

4 payments of $133.50 with Afterpay Learn more

Availability

Delivering to:

Estimated arrival:

  • Around 7-19 June using International Courier

Explore more Current Topics in Microbiology and Immunology

See all products in this series

Natural Killer Cells on Hardback
$413.99
Natural Killer Cells
Hardback
Available - Usually ships in 3-4 weeks
Influenza Pathogenesis and Control - Volume I on Hardback
$418.99
Influenza Pathogenesis and Control - Volume I
Hardback
Available - Usually ships in 3-4 weeks
Cancer Vaccines on Hardback
$412.99
Cancer Vaccines
Hardback
Available - Usually ships in 3-4 weeks
Phosphoinositides in Subcellular Targeting and Enzyme Activation on Hardback Save $142
$272.99
$415.95
Phosphoinositides in Subcellular Targeting and Enzyme Activation
Hardback
Available - Usually ships in 3-4 weeks
Current Topics in Microbiology and Immunology by W. Henle Save $24
$268.99
$293.95
Current Topics in Microbiology and Immunology
by W. Henle ~ Paperback / softback
Available - Usually ships in 3-4 weeks
Phosphoinositide 3-kinase in Health and Disease on Hardback Save $26
$535.99
$562.95
Phosphoinositide 3-kinase in Health and Disease
Hardback
Available - Usually ships in 3-4 weeks
Thymic Development and Selection of T Lymphocytes on Hardback Save $42
$268.99
$311.95
Thymic Development and Selection of T Lymphocytes
Hardback
Available - Usually ships in 3-4 weeks
CD4+CD25+ Regulatory T Cells: Origin, Function and Therapeutic Potential on Hardback Save $26
$535.99
$562.95
CD4+CD25+ Regulatory T Cells: Origin, Function and Therapeutic...
Hardback
Available - Usually ships in 3-4 weeks
Quasispecies: Concept and Implications for Virology on Hardback
$538.99
Quasispecies: Concept and Implications for Virology
Hardback
Available - Usually ships in 3-4 weeks
IgE Antibodies: Generation and Function on Hardback Save $67
$268.99
$335.99
IgE Antibodies: Generation and Function
Hardback
Available - Usually ships in 3-4 weeks
Retroviruses 3 Save $24
$268.99
$293.95
Retroviruses 3
Paperback / softback
Available - Usually ships in 3-4 weeks
Current Topics in Microbiology and Immunology by W. Henle Save $86
$138.99
$225.95
Current Topics in Microbiology and Immunology
by W. Henle ~ Paperback / softback
Available - Usually ships in 3-4 weeks
Epigenetic Regulation of Lymphocyte Development on Hardback Save $105
$411.99
$517.95
Epigenetic Regulation of Lymphocyte Development
Hardback
Available - Usually ships in 3-4 weeks
Anthrax on Hardback Save $104
$412.99
$517.95
Anthrax
Hardback
Available - Usually ships in 3-4 weeks
Interleukin-10 in Health and Disease
$268.99
Interleukin-10 in Health and Disease
Paperback / softback
Available - Usually ships in 3-4 weeks
HIV Interactions with Host Cell Proteins on Hardback
$602.99
HIV Interactions with Host Cell Proteins
Hardback
Available - Usually ships in 3-4 weeks

Description

The interplay between tumors and their immunologic microenvironment is complex, difficult to decipher, but its understanding is of seminal importance for the development of novel prognostic markers and therapeutic strategies. The present review discusses tumor-immune interactions in several human cancers that illustrate various aspects of this complexity and proposes an integrated scheme of the impact of local immune reactions on clinical outcome. Current active immunotherapy trials have shown durable tumor regressions in a fraction of patients. However, clinical efficacy of current vaccines is limited, possibly because tumors skew the immune system by means of myeloid-derived suppressor cells, inflammatory type 2 T cells and regulatory T cells (Tregs), all of which prevent the generation of effector cells. To improve the clinical efficacy of cancer vaccines in patients with metastatic disease, we need to design novel and improved strategies that can boost adaptive immunity to cancer, help overcome Tregs and allow the breakdown of the immunosuppressive tumor microenvironment.
Release date Australia
April 15th, 2011
Audience
  • Professional & Vocational
Contributor
  • Edited by Glenn Dranoff
Illustrations
xiv, 306 p.
Pages
306
Dimensions
155x235x23
ISBN-13
9783642141355
Product ID
7911272

Customer reviews

Nobody has reviewed this product yet. You could be the first!

Write a Review

Marketplace listings

There are no Marketplace listings available for this product currently.
Already own it? Create a free listing and pay just 9% commission when it sells!

Sell Yours Here

Recommended for you

Recommended from your browsing history

Help & options

Filed under...

Books >
Non-Fiction >
Professional & Technical >
Medicine >
Clinical & internal medicine >
Diseases & disorders >
Oncology
Books >
Non-Fiction >
Professional & Technical >
Medicine >
Clinical & internal medicine >
Diseases & disorders >
Immunology